Skip to main content


Page 1 of 38

  1. Diabetes is a complicated, chronic condition that requires ongoing medical attention as well as multiple risk-reduction measures beyond glucose control. The prevalence of chronic kidney disease (CKD) is highly...

    Authors: Eneyew Talie Fenta, Habitu Birhan Eshetu, Natnael Kebede, Eyob Ketema Bogale, Amare Zewdie, Tadele Derbew Kassie, Tadele Fentabil Anagaw, Elyas Melaku Mazengia and Sintayehu Shiferaw Gelaw
    Citation: Diabetology & Metabolic Syndrome 2023 15:245
  2. Most studies initiated basal-bolus insulin in a ratio of 1:1 and titrated based on glucose. This study aimed to investigate the effectiveness and safety of a weight-based and ratio of 1:1.5 basal-bolus insulin...

    Authors: Xiaodan Zhang, Dewen Yan, Tao Du, Yunjuan Zhao, Jiangong Zhang, Tong Zhang, Mingrun Lin, Yanli Li and Wangen Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:243
  3. Hypoglycemia is a barrier to optimal glucose control in the treatment of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Blood glucose monitoring is essential in diabetes management. Inappropriate gluc...

    Authors: Luciana Bahia, Karla F. Mello, Lívia Lovato Pires Lemos, Naiane Lima Costa, Eduardo Mulinari and Domingos A. Malerbi
    Citation: Diabetology & Metabolic Syndrome 2023 15:242
  4. The relationship between tea and coffee consumption and mortality among patients with metabolic syndrome (MetS) remains barely explored. Herein, this study aimed to examine the association between tea and coff...

    Authors: E Wu, Ying-Ying Bao, Guo-Fang Wei, Wei Wang, Hong-Quan Xu, Jia-Yin Chen, Ya-Nan Xu, Dan Han, Lin Tao and Jun-Tao Ni
    Citation: Diabetology & Metabolic Syndrome 2023 15:241
  5. Few studies have reported the adherence to and efficacy of continuous glucose monitoring (CGM) for improving diabetes management in insulin-treated older adults with type 2 diabetes mellitus (T2DM).

    Authors: Silmara A O Leite, Michael P Silva, Ana C R Lavalle, Maria C V Bertogy, Murilo Bastos, Suelen C Vieira Kuklik and Guillermo Umpierrez
    Citation: Diabetology & Metabolic Syndrome 2023 15:240
  6. Irisin plays a key role in metabolic diseases, including type 2 diabetes mellitus (T2DM). However, the mechanism underlying the link between irisin and the development of T2DM, particularly in pancreatic islet...

    Authors: Tianrong Li, Jingjing Yang, Anjun Tan and Hewen Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:239
  7. Serum remnant cholesterol levels are being increasingly acknowledged as a causal risk factor for atherosclerotic disease, regardless of conventional lipid parameters. The positive association between remnant c...

    Authors: Hangkai Huang, Jinghua Wang, Li Wu, Jiaqi Ruan, Linxiao Hou, Chao Shen and Chengfu Xu
    Citation: Diabetology & Metabolic Syndrome 2023 15:238
  8. There is a link between genetics with metabolic balance and adiposity homeostasis on metabolic syndrome (MetS). Polymorphism in adipokine genes such as leptin and adiponectin may play an important role in its ...

    Authors: Fred Luque Ortega, Alejandra Martínez Camberos, Martín Irigoyen Arredondo, Noemí García Magallanes and Eliakym Arámbula Meraz
    Citation: Diabetology & Metabolic Syndrome 2023 15:237
  9. Excellent blood glucose management is a key guarantee for successful progress of surgery. However, the impact of clinical pharmacists on blood glucose management of perioperative patients needs to be further i...

    Authors: Jinfang Song, Xiaojun Pan, Ya Chen, Yongjuan Ding and Xia Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:236
  10. Bile acids, which are steroid molecules originating from cholesterol and synthesized in the liver, play a pivotal role in regulating glucose metabolism and maintaining energy balance. Upon release into the int...

    Authors: Yisen Hou, Xinzhe Zhai, Xiaotao Wang, Yi Wu, Heyue Wang, Yaxin Qin, Jianli Han and Yong Meng
    Citation: Diabetology & Metabolic Syndrome 2023 15:235
  11. Microvascular dysfunction is one of the most common pathological characteristics in Type 2 diabetes. Human mesenchymal stem cell-derived exosomes (hUCMSCs-Exo) have diverse functions in improving microcirculat...

    Authors: Weijian Fan, Mengdie Zhou, Shaoqiu Zheng, Yang Liu, Songsong Pan, Peng Guo, Minjie Xu, Chao Hu, Anle Ding, Zan Wang, Shiwu Yin, Keqiang Zuo and Xiaoyun Xie
    Citation: Diabetology & Metabolic Syndrome 2023 15:234
  12. Ultra-processed food (UPF) consumption increases the risk of type 2 diabetes in various high-income countries, with some variation in the magnitude across studies. Our objective was to investigate the associat...

    Authors: Scheine L. Canhada, Álvaro Vigo, Renata Levy, Vivian C. Luft, Maria de Jesus M. da Fonseca, Luana Giatti, Maria del Carmen B. Molina, Bruce B. Duncan and Maria Inês Schmidt
    Citation: Diabetology & Metabolic Syndrome 2023 15:233
  13. Most studies about exercise interventions for patients with type 2 diabetes mellitus (T2DM) have been conducted in hospitals or labs, but it is unclear whether study findings from this specific condition can b...

    Authors: Chenyang Dong, Ruoya Liu, Zhiyang Huang, Yang Yang, Shiyuan Sun and Ran Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:232
  14. Although hypoalbuminemia was associated with high risk of mortality in community-dwelling older adults, as well as in the hospitalized older adults, little is known among centenarians. And there are limited da...

    Authors: Haowei Li, Shengshu Wang, Shanshan Yang, Shaohua Liu, Yang Song, Shimin Chen, Xuehang Li, Zhiqiang Li, Rongrong Li, Yali Zhao, Qiao Zhu, Chaoxue Ning, Miao Liu and Yao He
    Citation: Diabetology & Metabolic Syndrome 2023 15:231
  15. Chronic kidney disease (CKD) has emerged as a mounting public health issue worldwide; therefore, prompt identification and prevention are imperative in mitigating CKD-associated complications and mortality rat...

    Authors: Jihyun Yoon, Seok-Jae Heo, Jun-Hyuk Lee, Yu-Jin Kwon and Jung Eun Lee
    Citation: Diabetology & Metabolic Syndrome 2023 15:230
  16. Insulin resistance (IR) is a pivotal factor in the pathogenesis of type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Nevertheless, the impact of IR on cognitive dysfunction in T2DM...

    Authors: Hui Zhang, Huzaifa Fareeduddin Mohammed Farooqui, Wenwen Zhu, Tong Niu, Zhen Zhang and Haoqiang Zhang
    Citation: Diabetology & Metabolic Syndrome 2023 15:229
  17. The comorbidity rate between type 2 diabetes mellitus (T2DM) and pulmonary tuberculosis (PTB) is high and imposes enormous strains on healthcare systems. However, whether T2DM is causally associated with PTB i...

    Authors: Shengnan Chen, Weisong Zhang, Zhenquan Zheng, Xiaolong Shao, Peng Yang, Xiaobin Yang and Kai Nan
    Citation: Diabetology & Metabolic Syndrome 2023 15:228
  18. Several genetic risk scores (GRS) for type 2 diabetes (T2DM) have been published, but not replicated. We aimed to 1) replicate previous findings on the association between GRS on prevalence of T2DM and 2) asse...

    Authors: Sureka Nagarajah, Abdullah Alkandari and Pedro Marques-Vidal
    Citation: Diabetology & Metabolic Syndrome 2023 15:227
  19. Cardiometabolic multi-morbidity (CMM) is emerging as a global healthcare challenge and a pressing public health concern worldwide. Previous studies have principally focused on identifying risk factors for indi...

    Authors: Zenglei Zhang, Lin Zhao, Yiting Lu, Xu Meng and Xianliang Zhou
    Citation: Diabetology & Metabolic Syndrome 2023 15:226
  20. Diabetic retinopathy (DR) is a common complication of DM and may go unnoticed until irreversible damage occurs. Its screening can contribute to the early detection. Although, there are no studies which investi...

    Authors: Levimar Rocha Araújo, Juliana Lambert Orefice, Monica Aramuni Gonçalves, Nathalia Sernizon Guimarães, Aleida Nazareth Soares, Tassila Salomon and Alessandra Hubner de Souza
    Citation: Diabetology & Metabolic Syndrome 2023 15:225
  21. Sodium-glucose cotransporter (SGLT)2 inhibitors have displayed beneficial effects on the cardiovascular system in diabetes mellitus (DM) patients. As most clinical trials were performed in Type 2 DM, their eff...

    Authors: Eder Anderson Rodrigues, Camila Moreno Rosa, Dijon Henrique Salome Campos, Felipe Cesar Damatto, Gilson Masahiro Murata, Lidiane Moreira Souza, Luana Urbano Pagan, Mariana Gatto, Jessica Yumi Brosler, Hebreia Oliveira Almeida Souza, Mario Machado Martins, Luciana Machado Bastos, Suzana Erico Tanni, Katashi Okoshi and Marina Politi Okoshi
    Citation: Diabetology & Metabolic Syndrome 2023 15:223
  22. Glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 are the main incretin hormones, and be responsible for the insulinotropic incretin effect. The addition of a GIP agonist to a GLP-1agonist has been ...

    Authors: Qian Zhou, Xingxing Lei, Shunlian Fu, Pan Liu, Cong Long, Yanmei Wang, Zinan Li, Qian Xie and Qiu Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:222
  23. Physical exercise is the first-line intervention for prediabetes, and metformin is the most widely used oral insulin-sensitizing agent. Moreover, intermuscular adipose tissue (IMAT) directly affects insulin re...

    Authors: Fuyao Yu, Chuan Xing, Yiping Fan, Yanping Liu, Peng Su, Qiuhua Yang, Yanbin Dong, Yang Hou and Shinong Pan
    Citation: Diabetology & Metabolic Syndrome 2023 15:221
  24. Metabolic syndrome (MetS) is a group of metabolic abnormalities characterised by hypertension, central obesity, dyslipidaemia and dysregulation of blood glucose, associated with the risk of diabetes, cardiovas...

    Authors: Elena Raya-Cano, Rafael Molina-Luque, Manuel Vaquero-Abellán, Guillermo Molina-Recio, Rocío Jiménez-Mérida and Manuel Romero-Saldaña
    Citation: Diabetology & Metabolic Syndrome 2023 15:220
  25. Metabolic control and psychological management of paediatric type 1 diabetes mellitus (T1DM) can be challenging over time. Development of an instrument to assess the youth-reported burden could aid in preventi...

    Authors: Josep-Oriol Casanovas-Marsal, Elisa Civitani Monzón, M. Pilar Ferrer Duce, Marta Ferrer Lozano, Marta Vara Callau, Delia González de la Cuesta, Rosa Yelmo Valverde, Victoria Pérez Repiso, Irune Goicoechea Manterola and Antonio de Arriba Muñoz
    Citation: Diabetology & Metabolic Syndrome 2023 15:219
  26. Glucose fluctuations (GF) are a risk factor for cardiovascular complications associated with type 2 diabetes. However, there is a lack of adequate research on the effect of GF on myocardial fibrosis and the un...

    Authors: Lei Zhang, Huan-Huan Liu, Fan Yang, Zhi-Yuan Zhang, Zhen-Ye Zhang, Xiao-Xi Zhao, Ling-Ling Qian, Shi-Peng Dang and Ru-Xing Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:217
  27. Cardiovascular risk prediction models encompass numerous CVD risk factors. Available prediction models were developed from non-Asian cohorts hence we decided to evaluate the performance of the ASCVD risk estim...

    Authors: Ian Osoro, Ranjeet Kumar and Amit Sharma
    Citation: Diabetology & Metabolic Syndrome 2023 15:216
  28. Studies on the association of gestational diabetes mellitus (GDM) with osteoporosis, and bone mineral density (BMD) have been inconsistent. The aim of this study was to investigate the association of a history...

    Authors: Boqi Lu and Liping Zhang
    Citation: Diabetology & Metabolic Syndrome 2023 15:215
  29. Pemafibrate has been reported to ameliorate lipid profiles and liver dysfunction. However, which patients derive benefit from the hepatoprotective effects of pemafibrate is unclear.

    Authors: Hiroshi Nomoto, Kenichi Kito, Hiroshi Iesaka, Takahisa Handa, Shingo Yanagiya, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, So Nagai, Ichiro Sakuma, Akinobu Nakamura and Tatsuya Atsumi
    Citation: Diabetology & Metabolic Syndrome 2023 15:214
  30. Diabetic foot ulcers (DFUs) represent a significant foot-related concern for patients with multiple co-morbidities, and surgical intervention is often employed. Notably, peripheral nerve block anesthesia (PNB)...

    Authors: Gehua Zhu, Jiamin Xu, Hanying Dai, Dinghong Min and Guanghua Guo
    Citation: Diabetology & Metabolic Syndrome 2023 15:213
  31. Contradictory relationships have been observed between thyroid function and gestational diabetes mellitus (GDM). Previous studies have indicated that pre-pregnancy BMI (pBMI) could modify their relationships. ...

    Authors: Honglin Sun, Yibo Zhou, Jia Liu, Ying Wang and Guang Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:212
  32. Observational research reported the underlying correlation of metabolic syndrome (MetS) and its components with rotator cuff tendinopathy (RCT), but their causality remained unclear. This study aimed to invest...

    Authors: Ziqin Cao, Qiangxiang Li, Yajia Li and Jianhuang Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:211
  33. Both type 2 diabetes mellitus (T2DM) and frailty are strongly associated with congestive heart failure (CHF). Individuals with T2DM and CHF have a high frailty burden. The association of frailty with HF, all-c...

    Authors: Yu-Nan Qin and Xiao-Pu Zheng
    Citation: Diabetology & Metabolic Syndrome 2023 15:210
  34. Time-restricted eating (TRE), a feasible form of intermittent fasting, has been proven to benefit metabolic health in animal models and humans. To our knowledge, specific guidance on the appropriate period for...

    Authors: Zhongbiao Nie, Jiaming Xu, Yinchu Cheng, Zhihong Li, Ran Zhang, Wentao Zhang and Libo Zhao
    Citation: Diabetology & Metabolic Syndrome 2023 15:209
  35. The co-occurrence of cardiometabolic diseases (CMDs) is increasingly prevalent and has been associated with an additive risk of dementia in older adults, but the extent to which this risk can be offset by a he...

    Authors: Sizheng Xiong, Ningxin Hou, Feifei Tang, Jun Li and Hongping Deng
    Citation: Diabetology & Metabolic Syndrome 2023 15:208
  36. The prognostic nutritional index (PNI) and different glucose metabolisms have been separately reported to be correlated with long-term prognosis in patients with acute myocardial infarction (AMI) undergoing pe...

    Authors: Xuebin Ling, Chufen Lin, Jin Liu, Yibo He, Yongquan Yang, Na Lu, Wei Jie, Yong Liu, Shiqun Chen and Junli Guo
    Citation: Diabetology & Metabolic Syndrome 2023 15:207
  37. Maturity-onset diabetes of the young type 2 (MODY2) is a rare genetic disorder characterized as mild fasting hyperglycemia with low risk of vascular complications caused by glucokinase gene mutation. This stud...

    Authors: Jieying Liu, Ziyan Xie, Junling Fu, Miao Yu, Tong Wang, Cuijuan Qi, Peng Liu, Xiangyi Hui, Dongmei Wang, Lu Ding, Qian Zhang, Ting Xie and Xinhua Xiao
    Citation: Diabetology & Metabolic Syndrome 2023 15:206
  38. Advanced hybrid closed loop (AHCL) system provides both automated basal rate and correction boluses to keep glycemic values in a target range.

    Authors: Nancy Samir Elbarbary and Eman Abdel Rahman Ismail
    Citation: Diabetology & Metabolic Syndrome 2023 15:205
  39. The impact of triglyceride-glucose (TyG) index, a surrogate marker for insulin resistance, on the risk of cardiovascular disease (CVD) in general populations remains controversial. We aimed to comprehensively ...

    Authors: Yiming Wan, Ziliang Zhang, Yong Ling, Hui Cui, Zihan Tao, Jianfeng Pei, Aikedan Maimaiti, Haifan Bai, Yiling Wu, Jing Li, Genming Zhao and Maryam Zaid
    Citation: Diabetology & Metabolic Syndrome 2023 15:204
  40. Diabetes mellitus (DM) is associated with severe forms of COVID-19 but little is known about the diabetes—related phenotype considering pre-admission, on-admission and data covering the entire hospitalization ...

    Authors: Lais Isidoro Alves, Adriana Aparecida Bosco, Adriana Aparecida Rosa, Marcia Regina Soares Correia, Sergio Russo Matioli and Maria Elizabeth Rossi da Silva
    Citation: Diabetology & Metabolic Syndrome 2023 15:203
  41. Serum uric acid levels are higher in patients with type 2 diabetes and prediabetes compared to healthy individuals, and hyperuricemia causes a significant rate of complications and mortality through heart and ...

    Authors: Yinyuan You, Yu Zhao, Mujuan Chen, Ying Pan and Zhenhui Luo
    Citation: Diabetology & Metabolic Syndrome 2023 15:202
  42. The research was aimed to evaluate the subclinical left ventricular (LV) myocardial systolic dysfunction in T2DM patients with or without hypertension (HT) by global and segmental myocardial work (MW).

    Authors: Guang-An Li, Jun Huang, Xiao Sheng and Li Fan
    Citation: Diabetology & Metabolic Syndrome 2023 15:200
  43. Hypoglycemia is one of the most common complications in patients with DN during hemodialysis. The purpose of the study is to construct a clinical automatic calculation to predict risk of hypoglycemia during he...

    Authors: Rui-Ting Zhang, Yu Liu, Ke-Ke Lin, Wan-Ning Jia, Quan-Ying Wu, Jing Wang and Xiao-Yan Bai
    Citation: Diabetology & Metabolic Syndrome 2023 15:199
  44. Patients with diabetic ketoacidosis (DKA), a potentially fatal complication of type 1 diabetes, have hyperglycemia, ketonemia and metabolic acidosis. Blood glucose and blood ketone results are often used to tr...

    Authors: Eric S. Kilpatrick, Alexandra E. Butler, Sawsan Saeed, Naji Alamuddin, Stephen L. Atkin and David B. Sacks
    Citation: Diabetology & Metabolic Syndrome 2023 15:198
  45. Exposure to a hyperglycemic environment during prenatal life may result in an unfavorable metabolic profile later in adulthood. We aimed to assess whether fatty liver index, a non-invasive indicator of nonalco...

    Authors: Cedric A. Korpijaakko, Johan G. Eriksson, Hannu Kautiainen, Miira M. Klemetti and Merja K. Laine
    Citation: Diabetology & Metabolic Syndrome 2023 15:196
  46. This study aims to investigate the relationship between two novel inflammatory markers, namely, the Systemic Inflammatory Response Index (SIRI) and the Systemic Immune Inflammatory Index (SII), as well as the ...

    Authors: Fanliang Kong, Junhao Huang, Chunhua Xu, Tingyuan Huang, Grace Wen and Wenke Cheng
    Citation: Diabetology & Metabolic Syndrome 2023 15:195

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2022 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    84 days submission to accept (Median)

    2022 Usage 
    3,375 Altmetric mentions